March 31, 2022

Sydney, Australia, March 31, 2021 – The International Myopia Institute (IMI) is pleased to announce the launch of a global practitioner survey on myopia management uptake.

The International Myopia Institute (IMI) has developed key evidence-based resources that can be used by eye care practitioners to implement the best myopia management practices. While there has been a growing academic interest in myopia management over the past years, IMI is also interested to know what is happening in clinical practice around the globe.

“Receiving feedback directly from the eye practitioners would help IMI to identify areas that need further knowledge dissemination and understand factors that could hinder the practitioners to adopt best practice,” said IMI Chair, Professor Serge Resnikoff.

The International Myopia Institute survey on ‘myopia control attitudes and practice’ will build on data published in 2016 and 2019 to establish adoption of the latest evidence to address myopia epidemic and how this varies across the world.

“It is well established that clinical research can take several years to impact clinical practice. This survey will aid practitioners in benchmarking their practice, as well as identifying barriers to adoption. We would very much value your participation in promoting this survey,” said IMI Chief Scientist, Professor James Wolffsohn.

“The IMI ambassadors have been the forefront runner in adapting the survey to their local languages and distributing this survey through their channels. The survey will provide IMI with insightful information to address what is required to bridge the gap between research and clinical practice,” said IMI Project Director, Rebecca Weng.

The IMI global practitioner survey are currently available in the following languages:

The IMI white papers volume one and two and the latest clinical summaries in up to twelve international languages are available at



The International Myopia Institute was formed following the WHO-BHVI meeting on myopia and high myopia in 2015, due to the need to address the increasing levels of myopia and high myopia worldwide that can lead to potentially sight threatening complications for an individual, and the massive global burden associated with lost productivity.

The IMI is a global group of experts who have come together to discuss, debate, and make available the latest evidence-based recommendations in classifications, patient management, and research, in the form of the IMI white papers.

Our mission is to advance research, patient management and education in myopia to prevent future vision impairment and blindness associated with increasing myopia.  We aim to do this by bringing together, scientists, clinicians, policy makers, government, and educators into the field of myopia to stimulate collaboration and sharing of knowledge.

Founded by BHVI.

Supported by Zeiss, Essilor, CooperVision, Oculus and HOYA.

For further information, please contact:

Ms. Rebecca Weng, BOptom, Grad Cert OcTher, Grad Dip (I&T), MBA
Project Director, International Myopia Institute



No citation data has been entered for this IMI Whitepaper